Literature DB >> 1374245

Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cells.

Y Fukuda1, N Ishida, T Noguchi, A Kappas, S Sassa.   

Abstract

Effects of human interleukin-6 (hIL-6), the major acute phase inducer, on the expression of transcripts encoding cytochrome P450s were examined in human hepatoma-derived cells. Using reverse-transcription polymerase chain reaction, it was demonstrated that three hepatoma cell lines, HepG2, HepG2f and Hep3B, express P450 mRNAs encoding IA1, IA2 and IIIA3, the major P450 isozymes involved in carcinogen metabolism, and that they also show induction responses to treatment with their specific inducers. When hepatoma cells were treated with hIL-6, the levels of IA1, IA2 and IIIA3 mRNAs were markedly suppressed. These findings suggest that significant down regulation of cytochrome P450s may occur during the acute phase reaction, which may result in alterations in drug biotransformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374245     DOI: 10.1016/0006-291x(92)90684-d

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Use of established hepatoma cell lines in biotoxicology.

Authors:  M Ferro; A M Bassi; S Penco; G Nanni
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

Review 2.  Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations.

Authors:  S C Piscitelli; W G Reiss; W D Figg; W P Petros
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

3.  Defence capacity modulation of human hepatoma cell line Hep 3B by three pesticides.

Authors:  V Herno; B Descampiaux; M Kuczera; M Imbenotte; F Erb
Journal:  Bull Environ Contam Toxicol       Date:  1994-06       Impact factor: 2.151

4.  GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation.

Authors:  Yi-Cheng Wang; Yi-Ming Chen; Yan-Jun Lin; Shih-Ping Liu; En-Pei Isabel Chiang
Journal:  Mol Med       Date:  2011-01-03       Impact factor: 6.354

5.  Inhibition of cytochromes P4501A by nitric oxide.

Authors:  J Stadler; J Trockfeld; W A Schmalix; T Brill; J R Siewert; H Greim; J Doehmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Transforming growth factor-beta 1 inhibits TCDD-induced cytochrome P450IA1 expression in human lung cancer A549 cells.

Authors:  C Vogel; O Döhr; J Abel
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

7.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

Authors:  S L Nyberg; R P Remmel; H J Mann; M V Peshwa; W S Hu; F B Cerra
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

8.  Transient gene delivery for functional enrichment of differentiating embryonic stem cells.

Authors:  Eric J Wallenstein; Jeffrey Barminko; Rene S Schloss; Martin L Yarmush
Journal:  Biotechnol Bioeng       Date:  2008-12-01       Impact factor: 4.530

9.  Effect of carrageenan-induced granuloma on hepatic cytochrome P-450 isozymes in rats.

Authors:  J Muntané; V Longo; M T Mitjavila; P G Gervasi; M Ingelman-Sundberg
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

10.  The role of hepatic cytochrome P-450 in sepsis.

Authors:  Asha Jacob; Mian Zhou; Rongqian Wu; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.